Clinical Trials Directory

Trials / Terminated

TerminatedNCT01666405

Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

A Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Uroplasty, Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effectiveness of percutaneous tibial nerve stimulation (PTNS) therapy with the Urgent® PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA) for the treatment of fecal incontinence (FI).

Detailed description

Pilot Study

Conditions

Interventions

TypeNameDescription
DEVICEUrgent(R) PC Neuromodulation SystemThe Urgent PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA), device, is an easily administered neuromodulation system designed to deliver retrograde access to the sacral nerve through percutaneous electrical stimulation of the tibial nerve. This method of treatment is referred to as percutaneous tibial nerve stimulation (PTNS).

Timeline

Start date
2012-08-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2012-08-16
Last updated
2015-10-29

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01666405. Inclusion in this directory is not an endorsement.